What the Research Says
Iron is essential for hemoglobin synthesis, myoglobin, and mitochondrial electron transport. Iron deficiency exists on a spectrum from depleted stores to iron-deficiency anemia (IDA). WHO estimates 1.62 billion people have anemia, with iron deficiency accounting for ~50% of cases.
A 2011 Cochrane review of 67 trials found iron supplementation significantly improved fatigue and exercise capacity in IDA and non-anemic iron-deficient women. A 2014 meta-analysis found treating non-anemic iron deficiency (low ferritin, normal Hgb) also significantly reduced fatigue scores.
Symptoms & Stages of Iron Deficiency
Stage 1 — Depleted stores (low ferritin): Subtle fatigue, reduced exercise tolerance. Serum ferritin <30 ng/mL.
Stage 2 — Iron-deficient erythropoiesis: Reduced transferrin saturation. More pronounced fatigue and reduced concentration.
Stage 3 — Iron-deficiency anemia: Low hemoglobin (<12 g/dL women, <13 g/dL men). Pallor, dyspnea, significant fatigue, palpitations.
At-Risk Populations
- Menstruating women (monthly blood loss)
- Pregnant women (fetal demand)
- Endurance athletes (foot-strike hemolysis, GI blood loss)
- Vegetarians/vegans (lower non-heme iron bioavailability)
- Those with GI conditions (celiac, IBD, gastric bypass)
- Frequent blood donors
Documented Benefits of Correcting Deficiency
- Significant reduction in fatigue scores
- Improved aerobic exercise capacity and VO2max
- Better cognitive function and concentration
- Improved mood and reduced depressive symptoms
- Reduced restless legs syndrome symptoms
- Improved immune function
Iron Supplement Forms
- Ferrous bisglycinate: Better tolerated, fewer GI effects, good bioavailability — preferred
- Ferrous sulfate: Most studied, highly effective, affordable; GI side effects common
- Ferrous gluconate: Well-tolerated, slightly lower elemental iron content
- Ferric iron (Fe3+): Less bioavailable than ferrous forms
Dosage & Absorption Optimization
- Typical dose: 60–120mg elemental iron/day for IDA correction
- Optimal frequency: Alternate-day dosing improves absorption (hepcidin cycling)
- Take with Vitamin C: Significantly enhances non-heme iron absorption
- Avoid with: Calcium, coffee, tea — reduce absorption
- Retest: Ferritin and hemoglobin at 8–12 weeks
Frequently Asked Questions
Non-anemic iron deficiency can cause unexplained fatigue, reduced exercise tolerance, difficulty concentrating, cold intolerance, and increased susceptibility to infections. Research confirms these symptoms improve with iron supplementation even without anemia.
Most functional medicine and sports medicine practitioners use ferritin below 30 ng/mL as a threshold for insufficiency, and below 15 ng/mL as deficiency. Optimal levels for performance and wellbeing may be above 50 ng/mL, particularly in women.
Hemoglobin improvements are typically seen within 2–4 weeks. Fatigue symptoms often improve within 2–6 weeks. Full ferritin store repletion takes 3–6 months.
Testing is strongly recommended before supplementing. Iron overload (hemochromatosis) is a real risk — iron accumulates in organs and is toxic in excess. A basic panel (serum ferritin, hemoglobin, transferrin saturation) is needed before starting supplementation.
It is possible but requires attention. Plant foods contain non-heme iron with 2–20% bioavailability versus 15–35% for heme iron. Vegetarians can optimize by eating iron-rich plant foods with vitamin C, and avoiding tea/coffee with meals.
Research Summary
Iron deficiency is the world's most common nutritional deficiency with strong evidence for correction improving fatigue, cognition, and physical performance. Testing before supplementation is essential.
- Evidence strength: Strong (5/5)
- Best tolerated form: Ferrous bisglycinate
- Standard dose: 60–120mg elemental iron/day
- Key populations: Women, athletes, vegans
- Always test first: Ferritin + hemoglobin
References
All studies cited are peer-reviewed and publicly accessible. DOI and PubMed links open in a new tab.
- 1. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW (2021). Iron deficiency. Lancet, 397(10270), 233–248. doi:10.1016/S0140-6736(20)32594-0 PMID:33285139
- 2. Haas JD, Brownlie T (2001). Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. Journal of Nutrition, 131(2S-2), 676S–688S. doi:10.1093/jn/131.2.676S PMID:11160598
- 3. Vaucher P, Druais PL, Waldvogel S, Favrat B (2012). Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ, 184(11), 1247–1254. doi:10.1503/cmaj.110950 PMID:22777991
- 4. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ (2015). Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLOS ONE, 10(2), e0117383. doi:10.1371/journal.pone.0117383 PMID:25700159
- 5. Moretti D, Goede JS, Zeder C, et al. (2015). Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood, 126(17), 1981–1989. doi:10.1182/blood-2015-05-642223 PMID:26289641
- 6. WHO (2001). Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. World Health Organization, Geneva.